Knott David M Jr Abeona Therapeutics Inc. Transaction History

Knott David M Jr

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$3.71 - $5.14 $142,093 - $196,862	38,300 Added 23.94%	198,300 $993,000
Q1 2023 May 11, 2023	BUY	$2.25 - $3.27 $22,500 - $32,700	10,000 Added 6.67%	160,000 $451,000
Q4 2022 Feb 13, 2023	BUY	$2.4 - $5.65 $360,000 - $847,500	150,000 New	150,000 $462,000

26.9M

614K

45K

Ticker ABEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,950,380
Market Cap $33.9M
Description
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

Stay updated on Knott David M Jr with notifications on news.